Publications by authors named "Heayoung Shin"

Claim this Profile
A
Angiotensin receptor blocker versus angiotensin receptor-neprilysin inhibitor in improved HF with stabilized NT-proBNP levels.
Minjung Bak, Yoonjee Park, Darae Kim, Heayoung Shin, David Hong

Rev Esp Cardiol (Engl Ed)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Significance of Change in Left Atrial Strain during Weaning from Venoarterial Extracorporeal Membrane Oxygenation.
Heayoung Shin, Jihoon Kim, David Hong, Minjung Bak, Darae Kim

J Am Soc Echocardiogr· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Efficacy of Tafamidis in Korean ATTR-CM Patients: A Retrospective Observational Strain Analysis.
Heayoung Shin, Kina Jeon, Darae Kim, David Hong, Meesoon Park

Korean Circ J· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of SGLT2 inhibitors in patients with heart failure according to kidney function: a systematic review and meta-analysis.
David Hong, Minseok Hong, Onyou Kim, Heayoung Shin, Minjung Bak

Rev Esp Cardiol (Engl Ed)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial intelligence-enabled electrocardiogram model for predicting heart failure with preserved ejection fraction: a single-center study.
David Hong, Sung-Hee Song, Heayoung Shin, Minjung Bak, Juwon Kim

Eur Heart J Digit Health· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal Maintenance Strategy for Patients with Improved Left Ventricular Function Following Sacubitril/Valsartan Therapy.
Yoonjee Park, Minjung Bak, Heayoung Shin, David Hong, Jeong Hoon Yang

Medicina (Kaunas)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discontinuation rates, clinical effects and provocation factors of SGLT-2 inhibitor in the real world.
Minjung Bak, Sang Ah Chi, Kina Jeon, David Hong, Heayoung Shin

Sci Rep· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Projected Impact of Omidubicel-onlv on Racial/Ethnic Disparities in Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) Outcomes in Hematologic Malignancies.
Nandita Khera, Marie Louise Edwards, Yan Song, Rochelle Sun, Rocio Manghani, Heayoung Shin

Adv Ther· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Projected Impact of Omidubicel-onlv on Racial/Ethnic Disparities in Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) Outcomes in Hematologic Malignancies.
Nandita Khera, Marie Louise Edwards, Yan Song, Rochelle Sun, Rocio Manghani, Heayoung Shin

Adv Ther· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health care costs among patients with hematologic malignancies receiving allogeneic transplants: a US payer perspective.
Richard T Maziarz, Usama Gergis, Marie Louise Edwards, Yan Song, Qing Liu, Heayoung Shin

Blood Adv· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hospitalization and Healthcare Resource Utilization of Omidubicel-Onlv versus Umbilical Cord Blood Transplantation for Hematologic Malignancies: Secondary Analysis from a Pivotal Phase 3 Clinical Trial.
Navneet S Majhail, Beckley Miller, Rebecca Dean, Rocio Manghani, Heayoung Shin

Transplant Cell Ther· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis